Missling says Anavex will partner. I believe that he will do as he says. The major biggest reason is a launch of a drug is expensive and requires a totally different setup than R&D. It requires way more ppl and I do not believe Missling wants to focus on trying to manage the sale side of this product. There are too many other possible drug indications and disease state that will need to be developed and if Anavex using working capital to launch a drug then the funding of these programs will altogether out a strain on Anavex from a financial point of view.
Look for a partner in the near future. Just my 2 cents...
News 
Market Data 
Discover 
